ClinicalTrials.gg
RecruitingNCT07860918RBV-HFJVUpdated Nov 2, 2026

Clinical Effects of Different Ventilation Strategies in Rigid Bronchoscopy Procedures

An interventional study of Jet Ventilation and Spontaneous Assisted Ventilation in Rigid Bronchoscopy Ventilation, sponsored by The Affiliated Hospital of Qingdao University. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by The Affiliated Hospital of Qingdao University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 2, 2026Now RecruitingSite recruiting status changed+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This study compares the effects of different ventilation strategies on patient safety and respiratory parameters during rigid bronchoscopy procedures. It enrolls patients undergoing the procedure at Qingdao University Affiliated Hospital, aiming to identify the optimal ventilation mode to reduce complications.

02

Conditions studied

  • Rigid Bronchoscopy Ventilation
03

In context

Lead sponsor

The Affiliated Hospital of Qingdao University is the lead sponsor of 151 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients scheduled for elective interventional rigid bronchoscopy, who agree to participate in this study and have no to anesthesia.

Exclusion criteria

Exclusion Criteria:

  • History of allergic reaction to anesthetic agents;
  • Pregnancy;
  • Severe dysfunction of the heart, lung, liver, kidney or other vital organs;
  • Cognitive impairment or neurological diseases;
  • to succinylcholine (e.g., hyperkalemia, extensive burns, severe trauma, crush injury, spinal cord injury, paraplegia, hemiplegia, myasthenia gravis, etc.); Refusal to participate in this study by the patient or their family members.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
150 participants (estimated)

Study arms

  • Active comparator
    Jet Ventilation

    Procedure: Jet Ventilation

  • Experimental
    Spontaneous Assisted Ventilation

    Procedure: Spontaneous Assisted Ventilation

Interventions

  • ProcedureJet Ventilation

    Jet ventilation delivered throughout rigid bronchoscopy procedure

  • ProcedureSpontaneous Assisted Ventilation

    Spontaneous assisted ventilation applied during rigid bronchoscopy to preserve patients' spontaneous breathing

06

What researchers measure

Primary outcomes

  1. peripheral oxygen saturation

    Use pulse oximetry to continuously monitor and record peripheral oxygen saturation (SpO₂) values throughout the study period, to evaluate the incidence and duration of hypoxemia.

    Time frame: From enrollment to study completion, continuous monitoring during the entire observation period

Secondary outcomes

  1. arterial blood pH

    Collect arterial blood pH values by arterial blood gas analysis to assess the acid-base status of subjects.

    Time frame: Measurements will be performed 10 minutes after initiation of each respective ventilation mode.

  2. arterial partial pressure of carbon dioxide

    Collect arterial partial pressure of carbon dioxide (PaCO₂) via arterial blood gas analysis.

    Time frame: 10 minutes after initiation of each ventilation mode

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

3 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for May 2027, 7 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 1, 2026
First posted
Oct 6, 2026
StartEst.
Oct 2, 2026
Primary completionEst.
May 31, 2027
CompletionEst.
Jun 1, 2027
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 2, 2026
Sites
The Affiliated Hospital of Qingdao University is now Recruiting
Nov 2, 2026
Start date
Oct 1, 2026→Oct 2, 2026
Nov 2, 2026
Study completion
Jun 30, 2027→Jun 1, 2027
Nov 2, 2026
Registered
First appeared on the registry
Oct 6, 2026
Show all 3 updates
  1. Nov 2, 2026
    Not yet recruiting→Recruiting
    The Affiliated Hospital of Qingdao University is now Recruiting
    Start date Oct 1, 2026→Oct 2, 2026
    Study completion Jun 30, 2027→Jun 1, 2027
  2. Oct 13, 2026
    Minor edits only
    + 1 other change: criteria formatting
  3. Oct 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07860918
Responsible party
jixiangyu (Principal Investigator, The Affiliated Hospital of Qingdao University) — Principal investigator
First posted
Oct 6, 2026
Start date
Oct 2, 2026 (estimated)
Primary completion
May 31, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Nov 2, 2026

Study contacts

Xiangyu Ji
Contact
jixiangyu@qdu.edu.cn
17853298922

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion